Abstract:Cognitive impairment is a common central nervous system complication that occurs following surgery or organs damage outside the nervous system. Neuroinflammation plays a key role in the molecular mechanisms of cognitive impairment. Dexmedetomidine alleviates neuroinflammation and reduces cognitive dysfunction incidence; however, the mechanism by which dexmedetomidine alleviates cognitive dysfunction remains unclear. This study evaluated the effect of dexmedetomidine on attenuation of early cognitive impairment induced by intestinal ischemia–reperfusion in mice and examined whether the locus coeruleus norepinephrine (LCNE) system participates in the anti-inflammatory effect of dexmedetomidine. The superior mesenteric artery was clamped for 45 min to induce intestinal ischemia reperfusion injury. Dexmedetomidine alone or combined with DSP-4, a selective locus coeruleus noradrenergic neurotoxin, was used for pretreatment. Postoperative cognition was assessed using the Morris water maze. Serum and hippocampal levels of IL-1β, TNF-α, norepinephrine (NE), and malondialdehyde (MDA) were assessed by enzyme-linked immunosorbent assay. Immunofluorescence, immunohistochemistry, and hematoxylin and eosin staining were used to evaluate the expression of tyrosine hydroxylase (TH) in the locus coeruleus, hippocampal microglia, and intestinal injury. Pretreatment with dexmedetomidine alleviated intestinal injury and decreased the serum and hippocampal levels of NE, IL-1β, TNF-α, and MDA at 24 h after intestinal ischemia reperfusion, decreased TH-positive neurons in the locus coeruleus, and ameliorated cognitive impairment. Similarly, DSP-4 pre-treatment alleviated neuroinflammation and improved cognitive function. Furthermore, α2-adrenergic receptor antagonist atipamezole or yohimbine administration diminished the neuroprotective effects and improved cognitive function with dexmedetomidine. Therefore, dexmedetomidine attenuated early cognitive dysfunction induced by intestinal ischemia–reperfusion injury in mice, which may be related to its anti-inflammatory effects through the LCNE system.

Involvement of Spinal Microglia and Interleukin-18 in the Anti-Nociceptive Effect of Dexmedetomidine in Rats Subjected to CCI

Dexmedetomidine Suppresses Oxidative Stress and Inflammation of Nucleus Pulposus Cells by Activating the PI3K/Akt Signaling Pathway.

Anti-nociceptive effect of dexmedetomidine in a rat model of monoarthritis via suppression of the TLR4/NF-κB p65 pathway.

Intrathecal injection of dexmedetomidine ameliorates chronic neuropathic pain via the modulation of MPK3/ERK1/2 in a mouse model of chronic neuropathic pain

Dexmedetomidine alleviates anxiety-like behavior in mice following peripheral nerve injury by reducing the hyperactivity of glutamatergic neurons in the anterior cingulate cortex

Dexmedetomidine Induces Microglial Activation and Modulates Microglial M1/M2 Polarization in Attenuation of Chronic Morphine Tolerance in Cancer Pain

Evidence for Suppression of Spinal Glial Activation by Dexmedetomidine in A Rat Model of Monoarthritis

Dexmedetomidine Attenuates Persistent Postsurgical Pain by Upregulating K+–Cl− Cotransporter-2 in the Spinal Dorsal Horn in Rats

The Effects of Dexmedetomidine Pretreatment on the Pro- and Anti-Inflammation Systems after Spinal Cord Injury in Rats

The role of NLRP3 inflammasome in dexmedetomidine alleviating neuropathic pain after brachial plexus injury in rats

Dexmedetomidine Blocks Thermal Hyperalgesia and Spinal Glial Activation in Rat Model of Monoarthritis

Dexmedetomidine relieves inflammatory pain by enhancing GABAergic synaptic activity in pyramidal neurons of the anterior cingulate cortex

Effect of Dexmedetomidine on Content of Nitric Oxide and Activity of Nitric Oxide Synthase in Cerebral Cortex in Rat Neuropathic Pain Model

Dexmedetomidine Prevents Remifentanil-Induced Postoperative Hyperalgesia and Decreases Spinal Tyrosine Phosphorylation of N-methyl-d-aspartate Receptor 2B Subunit.

Alpha 2-adrenoceptor participates in anti-hyperalgesia by regulating metabolic demand

Dexmedetomidine modulates transient receptor potential vanilloid subtype 1

Dexmedetomidine Attenuates Haemorrhage-Induced Thalamic Pain by Inhibiting the TLR4/NF-κB/ERK1/2 Pathway in Mice

Effect of Dexmedetomidine on Expression of C-Fos Protein in Dorsal Root Ganglion Neurons in a Rat Model of Neuropathic Pain

Dexmedetomidine Ameliorated Cognitive Dysfunction Induced by Intestinal Ischemia Reperfusion in Mice with Possible Relation to the Anti-inflammatory Effect Through the Locus Coeruleus Norepinephrine System

Dexmedetomidine inhibits microglial activation through SNHG14/HMGB1 pathway in spinal cord ischemia-reperfusion injury mice